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Inhibition of Staphylococcus aureus biofilm
by Lactobacillus isolated from fine cocoa
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Abstract
Background: Biofilm production represents an important virulence and pathogenesis factor for Staphylococcus
aureus. The formation of biofilms on medical devices is a major concern in hospital environments, as they can
become a constant source of infection. Probiotic bacteria, such as Lactobacillus fermentum and L. plantarum, have
been found to inhibit biofilm formation; however little is known about the underlying mechanism. In this study, we
tested the activity of supernatants produced by L. fermentum TCUESC01 and L. plantarum TCUESC02, isolated
during the fermentation of fine cocoa, against S. aureus CCMB262 biofilm production. We measured inhibition of
biofilm formation in vitro and analyzed biofilm structure by confocal and electronic microscopy. Additionally, we
quantified the expression of S. aureus genes icaA and icaR involved in the synthesis of the biofilm matrix by real-
time PCR.
Results: Both Lactobacillus supernatants inhibited S. aureus growth. However, only L. fermentum TCUESC01
significantly reduced the thickness of the biofilm, from 14 μm to 2.83 μm (at 18 mg mL−1, 90 % of the minimum
inhibitory concentration, MIC), 3.12 μm (at 14 mg mL−1, 70 % of the MIC), and 5.21 μm (at 10 mg mL−1, 50 % of
the MIC). Additionally, L. fermentum TCUESC01 supernatant modulated the expression of icaA and icaR.
Conclusions: L. fermentum TCUESC01 reduces the formation of S. aureus biofilm under subinhibitory conditions.
Inhibition of biofilm production probably depends on modulation of the ica operon.
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Background
Staphylococcus aureus is a widely distributed and oppor-
tunistic human pathogen. It is the causative agent of
both simple skin infections and potentially life-threatening
systemic complications such as toxic shock syndrome [1].
S. aureus is a major concern in hospital environments be-
cause asymptomatic carriers represent a great risk factor
to patients subjected to long hospitalization periods [2].
Some aspects of S. aureus pathogenicity are related to
biofilm production, which increases resistance to chemo-
therapeutic treatments and to the host’s defense mecha-
nisms [3]. The biofilm is composed of cells adhering to a
surface and held together by a polymer matrix. The main
components of the matrix are polysaccharides, proteins,
and extracellular DNA (eDNA) [4].
S. aureus secretes polysaccharides of intercellular ad-
hesion (PIAs), which are composed mostly of β-1, 6-N-
acetylglucosamine residues. PIA production and excre-
tion is controlled by the icaADBC operon [5]. icaA, the
first gene to be transcribed, leads to production of short
chains of N-acetylglucosamine oligomers [6]. icaD, co-
expressed with icaA, enhances oligomer production by
about 20 fold [7, 8]. icaC is responsible for increasing
oligomer chains and possibly for translocation to the cell
surface [8, 9]. Finally, icaB is thought to deacetylate
poly-N- acetylglucosamines [9]. The icaADBC locus is
regulated by a transcriptional repressor located upstream
encoded by icaR [10]. This repressor protein can bind to
the ica operon promoter region close to the icaA start
codon [8]. Additional factors that can negatively influ-
ence the ica operon in S. aureus include expression of
the weak repressor TcaR, global regulation by SarA, and
the insertion sequence element IS256 in the ica locus [8,
11]. The ica operon is also regulated by environmental
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factors, which play an important role in the response to
anaerobic growth (SrrAB), in the response to stress
(Spx), supplementation with glucose or ethanol, osmo-
larity, temperature, and low concentrations of antibiotics
[8, 11, 12]. Another way of controlling this operon is
through a regulatory protein responsible for biofilm for-
mation, Rbf, which can repress transcription of IcaR and
indirectly increase expression of the gene icaADBC [11].
S. aureus biofilms are commonly treated with antibi-
otics, such as protein synthesis inhibitors that target the
cell membrane and cell wall, as well as inhibitors of
DNA and RNA synthesis [4], or antimicrobials like Cu2+
that lead to cell membrane breakage and subsequent cell
lysis [13]. The indiscriminate use of antibiotics for the
treatment of bacterial infections has been suggested to
be responsible for the appearance of multidrug-resistant
bacteria such as methicillin-resistant S. aureus strains
[14]. In this context, alternatives to antibiotic therapy
are more than welcome. Probiotics represent a possible
option, as the microorganisms that produce them have
been proven effective in the prevention and control of
human pathogens [15].
Lactobacillus fermentum TCUESC01 and L. plantarum
TCUESC02 strains have been recently isolated from the
fermentation of fine cocoa seeds. Our group has
demonstrated their anti-inflammatory potential and
technological properties. We observed that these strains
exhibited probiotic characteristics in vivo in an experi-
mental colitis model, reducing histological damage and
the systemic concentration of inflammatory cytokines.
Additionally, they inhibited the growth of pathogenic
bacteria and displayed high resistance to the stressful
conditions of the gastrointestinal tract and industrial envi-
ronments (unpublished observations). In this study, we
evaluated the activity of cell-free supernatant from L.
fermentum TCUESC01 and L. plantarum TCUESC02 on
S. aureus CCMB262 biofilm formation.
Methods
Microorganisms and culture conditions
Pure cultures of L. fermentum TCUESC01, L. plantarum
TCUESC02, and S. aureus CCMB262 were used.
TCUESC01 and TCUESC02 strains were previously iso-
lated by our group during fine cocoa fermentation [16].
The cultures were stored at −80 °C in 10 % skim milk
(Molico®, Nestlé, São Paulo Brazil) with 30 % glycerol.
Lactobacilli were cultured in de Man, Rogosa, and Sharpe
(MRS) broth (1 % peptone, 0.8 % meat extract, 0.4 % yeast
extract, 2 % glucose, 0.5 % sodium acetate, 0.2 % dipotas-
sium hydrogen phosphate, 0.02 % magnesium sulfate epta-
hydrate, 0.005 % manganese sulfate tetrahydrate, 0.02 %
triammonium citrate) (HiMedia®, Mumbai, India), for 48 h
at 37 °C. Species identity was confirmed by 16S rDNA
sequencing and strains were deposited in the GenBank
database [17] under accession numbers KU244478 and
KU244476.
S. aureus CCMB262 was obtained from the Microor-
ganisms Culture Collection of Bahia (CCMB), Brazil.
The strain, which is resistant to streptomycin and dihy-
drostreptomycin, was cultured in tryptic soy broth (TSB;
DIFCO, Becton Dickinson, Franklin Lakes, NJ, USA) sup-
plemented with 1 % (w/v) glucose (Glc) at 37 °C with agi-
tation (250 rpm) for 18 h. For inoculum standardization,
S. aureus cells were homogenized in saline solution (NaCl
0.85 %) and the suspension was diluted to 0.5 ×
108 CFU∙mL−1 using a spectrophotometer (Evolution 60,
Thermo Fisher Scientific, Waltham, MA, USA).
Supernatant preparation and lyophilization process
L. fermentum TCUESC01 and L. plantarum TCUESC02
were cultured in 30 mL of MRS broth. Following centrifu-
gation at 10,000 × g for 15 min at 4 °C, culture supernatants
were collected and filtered through a 0.22 μm nitrocellulose
membrane. Supernatants and samples containing medium
culture only (control) were frozen at −80 °C for 24 h and
lyophilized (Lyophilizer LS3000, Terroni, São Carlos,
Brazil). Following lyophilization, the samples were weighed
and stored at −20 °C. They were then rehydrated with
sterile deionized water prior to use.
Minimum inhibitory concentration (MIC) assay
MIC assays were performed by microdilution in 96-well
plates (Costar®, Corning, NY, USA), in accordance with
recommendations from the Clinical and Laboratory
Standards Institute [18]. A serial dilution was performed
starting with 40 μg∙mL−1 of TCUESC01 and TCUESC02
supernatants on Mueller Hinton (MH) medium containing
5 × 105 CFU∙mL−1 of S. aureus CCMB262 per well. The
same procedure was performed with the following con-
trols: lyophilized medium without Lactobacillus (MRS con-
trol); MH without inoculum (medium sterility control -
MC); MH containing 5 × 105 CFU∙mL−1 of S. aureus
CCMB262 (positive control); MH containing 5 ×
105 CFU∙mL−1 of S. aureus CCMB262 and 12.5 μg∙mL−1
chloramphenicol (negative control). The microplate was
incubated for 24 h at 37 °C and revealed with 20 μL of
Resazurin (0.01 %) for 30 min at 37 °C. At the same time,
5 μL of each suspension (samples and control) was cul-
tured on MH agar (MHA; DIFCO) for 24 h at 37 °C, after
which the inhibitory concentrations were classified as
bactericidal or bacteriostatic. The entire experiment was
performed three times with three independent repetitions.
Preparation of subinhibitory concentrations of TCUESC01
and TCUESC02 supernatants
To avoid killing all S. aureus, lyophilized supernatants
of the two Lactobacillus strains were weighed and di-
luted to concentrations below the MIC. Thus, dilutions
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were made using subinhibitory concentrations of 90,
70, and 50 % of MIC.
Biofilm formation on a polystyrene plate
The ability of S. aureus to form biofilms following treat-
ment with Lactobacillus supernatant was analyzed ac-
cording to the methodology proposed by Oliveira et al.
(2014) [19]. Briefly, S. aureus CCMB262 was cultured in
5 mL TSB with 1 % Glc for 18 h at 37 °C under agitation
(250 rpm) and treated with Lactobacillus supernatants
(90 %, 70 %, or 50 % of the MIC) or control medium.
The cultures were diluted (1:100) in the same medium,
200 μL was inoculated in a 96-well plate (Costar®), and
plates were incubated at 37 °C for 24 h. The plates were
washed twice with phosphate-buffered saline (PBS),
dried for 1 h at 65 °C, 1 % crystal violet was added, and
the plates were incubated for a further 30 min at 25 °C.
Each well was washed twice with PBS and 200 μL PBS
was added prior to measuring absorbance at 492 nm
(A492nm) using a microplate reader (VersaMax; Molecu-
lar Devices®, Sunnyvale, CA, USA). The experiment was
carried out in quadruplicate with at least two independ-
ent experiments. Biofilm production was compared to
that of Streptococcus pyogenes ATCC75194 (A492nm =




where x is the optical density at A492nm of the biofilm
and y is the optical density at A492nm of Streptococcus
pyogenes (0.07).
Based on the BFI, S. aureus cultures were classified
as non-producers (less than or equal to zero), weak
producers (less than 1), moderate producers (between
Fig. 1 a Effect of minimum inhibitory concentration (MIC) of Lactobacillus fermentum TCUESC01 and L. plantarum TCUESC02 supernatants on
Staphylococcus aureus CCMB262 growth. MRS Control, MRS medium without lyophilized Lactobacillus cells; PC, positive control for S. aureus; NC,
negative control, S. aureus with 12.5 μg mL−1 chloramphenicol; MC, sterility control of MH medium. b Bactericidal/bacteriostatic activity of L.
fermentum TCUESC01 and L. plantarum TCUESC02 supernatants (at MIC doses) against S. aureus CCMB262 grown on MHA
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1 and 2), producers (between 2 and 3), or strong bio-
film producers (greater than 4).
Biofilm evaluation by confocal laser scanning microscopy
S. aureus CCMB262 biofilm viability was assessed ac-
cording to Hobby et al. (2012) with some modifications
[20]. S. aureus CCMB262 was cultured in TSB with 1 %
Glc for 18 h at 37 °C in 12-well culture plates (Costar®)
containing 18 mm coverslips. Cells were cultured in the
presence of L. fermentum TCUESC01 (90, 70, and 50 %
of MIC) and L. plantarum TCUESC02 (90 and 70 % of
MIC) supernatants or control medium. Microplates were
incubated for 18 h at 37 °C, then coverslips were washed
twice with 0.85 % NaCl and stained with 0.3 μg∙mL−1 4′,
6′-diamidino-2-phenylindole (DAPI; Molecular Probes,
Carlsbad, CA, USA) and 2.5 μg∙mL−1 propidium iodide
(PI; Invitrogen, Carlsbad, CA, USA) for 15 min in the
dark. The coverslips were observed with a confocal laser
scanning microscope (Carl Zeiss LSM 700; Jena,
Germany), equipped with an argon laser at 488 nm and
two helium/neon lasers at 543 nm.
Cultivation of S. aureus CCMB262 in the presence or
absence of L. fermentum TCUESC01 supernatant at a
subinhibitory dose (50 % of MIC)
To confirm that the concentration used to inhibit the
biofilm was not lethal to S. aureus, a growth curve was
constructed. S. aureus (75 μL, 0.5 × 108 CFU∙mL−1) was
inoculated in 75 mL TSB with 1 % Glc and cultivated in
the presence or absence of 750 mg of TCUESC01 super-
natant (50 % of MIC) for 24 h at 37 °C under agitation
(250 rpm). Aliquots were collected every 4 h to record
optical density at 660 nm and count CFU∙mL−1 in
mannitol salt agar.
Phenotypic evaluation of biofilms by scanning electron
microscopy (SEM)
The phenotype of S. aureus CCMB262 biofilm was eval-
uated by SEM according to Pitino et al. (2012) with
some modifications [21]. S. aureus was cultured in TSB
with 1 % Glc in the presence or absence of TCUESC01
supernatant in 12-well culture plates (Costar®) contain-
ing 18 mm coverslips. After incubation for 24 h at 37 °C,
the coverslips were washed twice with 0.85 % NaCl and
dehydrated with 50, 60, 70, 80, and 90 % acetone for
10 min each, and twice with 100 % acetone for 10 min.
The coverslips were subsequently dehydrated in a critical
point dryer CPD 030 (BAL-TEC®, Balzers, Germany)
using liquid carbon dioxide as transition fluid. The sam-
ples were placed in aluminum pieces, metallized with a
SCD-050 (BAL-TEC®, Alzenau, Germany), and viewed
under a scanning electron microscope (Quanta 250, FEI,
Hillsboro, OR, USA).
Total RNA extraction
S. aureus CCMB262 was cultured in TSB with 1 % Glc
for 18 h at 37 °C under agitation (250 rpm), in the pres-
ence or absence of L. fermentum TCUESC01 supernatant
(50 % of the MIC). The samples were then diluted in the
same medium (1:100) and incubated at 37 °C for another
18 h, after which aliquots were collected and used imme-
diately for RNA extraction.
Each sample (1 mL) was centrifuged at 10,000 × g for
10 min at 4 °C. The supernatant was discarded and
RNA from the pellet was extracted with the RNAqu-
eous® Phenol-free total RNA isolation kit (Ambion®,
Waltham, MA, USA), according to the manufacturer’s
Fig. 3 S. aureus CCMB262 growth in the presence or not of L.
fermentum TCUESC01 supernatant at a subinhibitory dose (50 % of
MIC).● and continuous line, standard growth curve with S. aureus
CCMB262 (control); □ and dashed line, growth curve of S. aureus
CCMB262 with addition of L. fermentum TCUESC01 supernatant at
50 % of the MIC (10 mg mL−1). The result represents the average
of three experiments
Fig. 2 Biofilm formation index for S. aureus CCMB262 treated or not
with TCUESC01 and TCUESC02 supernatants. ■, L. fermentum
TCUESC01; □, L. plantarum TCUESC02; N, untreated control; 90, 70,
and 50 %, MIC doses used for the treatment; *, statistical significance
compared to the control (p < 0.001)
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recommendations. The RNA was visualized on a 1 %
agarose gel and quantified with a NanoDrop 2000 spec-
trophotometer (Thermo Fisher Scientific).
Reverse transcription, PCR, and real-time PCR
cDNA was synthesized using 25 mg RNA and the Super-
Script™ First-Strand Synthesis System for RT-PCR kit
(Invitrogen) following the manufacturer’s protocol. Spe-
cific primers (Invitrogen) were selected according to Yu et




rRNA S. aureus Forward (5′-CGTGGAGGGTCATTGG
A-3′), Reverse (5′-CGTTTACGGCGTGGACT-3′). Amp-
lification was carried out in a Mastercyler Gradient Nexus
Thermal Cycler (Eppendorf, Hauppage, NY, USA). The
cDNA was then quantified with a NanoDrop 2000 spec-
trophotometer (Thermo Fisher Scientific).
Gene expression analysis was carried out on a 7500
Fast real-time PCR system (Applied Biosytems,
Waltham, MA, USA), using 10 ng cDNA and the
KAPA SYBR® qPCR Master Mix ABI Prism™ kit
(Kapa Biosystems, Wilmington, MA, USA) according
to the manufacturer’s recommendations. The PCR re-
action was carried out in quintuplicate with an initial
denaturation at 95 °C for 5 min followed by 40 cycles
of amplification at 95 °C for 20 s, 60 °C for 20 s,
and 72 °C for 20 s. Data were normalized to16S
rRNA (endogenous control) and the relative quantifi-
cation (RQ) was calculated with 7500 Software v 2.3
(Applied Biosytems).
Fig. 4 Confocal microscopy of S. aureus CCMB262 treated with L. fermentum TCUESC01 and L. plantarum TCUESC02 supernatants at subinhibitory
doses. Treatments were as follows: a untreated S. aureus CCMB262; b TCUESC02 at 90 % of the MIC (2.25 mg mL−1); c TCUESC02 at 70 % of the
MIC (1.75 mg mL−1); d TCUESC01 at 90 % of the MIC (18 mg mL−1); e TCUESC01 at 70 % of the MIC (14 mg mL−1); f TCUESC01 at 50 % of
the MIC (10 mg mL−1). The biofilm was stained with DAPI (blue, panel 2) and PI (red, panel 3); panel 1 shows the overlapping of panels 2 and 3
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Statistical analysis
Average, standard deviation, t-test, analysis of vari-
ance, Tukey’s multiple comparison test, graphics, and
other statistical analyses were performed using the
Graphpad® prism 5.0 software (GraphPad Software,
San Diego, CA, USA).
Results and discussion
Antimicrobial susceptibility tests revealed that the super-
natant from L. plantarum TCUESC02 had a stronger in-
hibitory effect on S. aureus CCMB262 growth (MIC,
2.5 mg∙mL−1) than that of L. fermentum TCUESC01
(MIC, 20 mg∙mL−1) (Fig. 1). The potential of Lactobacil-
lus species to inhibit pathogens of clinical importance
such as S. aureus had been evaluated before. Accord-
ingly, Al Kassaa et al. (2014) showed that L. fermentum
CMUL054 and L. plantarum CMUL140 were active
against S. aureus ATCC33862 [23]. Moreover, Hor and
Liong (2014) analyzed 87 lactic acid bacteria strains and
three strains of bifidobacteria, and found that all strains
inhibited the growth of S. aureus by 0.5 to 34.2 %; L.
fermentum and L. plantarum, which were isolated from
milk, inhibited growth by around 20 % [24]. Although
inhibition of S. aureus by lactic bacteria has been
reported in many studies [23–26], few of them have
calculated the MIC from extracellular bacterial extracts.
This has made it difficult to assess the extracts’ inhibitory
action. Lactobacilli produce various secondary metabolites
that exhibit antimicrobial activity, such as organic acids,
ethyl alcohol, bacteriocins, hydrogen peroxide, and surfac-
tants [15, 26–28]. The strains used in this study were
isolated during cocoa fermentation, a process character-
ized by high temperature conditions, low oxygen concen-
trations, and low glucose availability. Lactobacilli are
probably selected for their ability to withstand these
conditions, which makes them an interesting source of
compounds with biological activities of human interest.
S. aureus CCMB262 is regarded as a strong biofilm pro-
ducer (BFI 17.39). After treatment with L. fermentum
TCUESC01 supernatant, we noticed a significant reduc-
tion in the BFI (p < 0.001). Upon treatment with 90 %
(18 mg∙mL−1) and 70 % of the MIC (14 mg∙mL−1), classifi-
cation of S. aureus CCMB262 changed from strong to
moderate biofilm producers (BFI 1.55 and 1.69 respect-
ively); it went from strong to biofilm producer (BFI 3.3)
when treated with 50 % of the MIC (10 mg∙mL−1) (Fig. 2).
L. plantarum TCUESC02 was less effective against S.
aureus CCMB262 biofilm formation (MIC, 2.5 mg∙mL−1).
We found a significant difference in the BFI only when
using 90 % of the MIC (p < 0.01), meaning that S. aureus
CCMB262 was still a strong biofilm producer. We did not
observe statistically significant differences between treat-
ments with 90 % (2.25 mg∙mL−1) or 70 % of the MIC
(1.75 mg∙mL−1) for this strain. In a previous report, the
supernatant of L. bulgaricus FTDC8611 inhibited signifi-
cantly S. aureus biofilm, an effect attributed to organic
acids [24]. Also, Ait Ouali et al.(2014) demonstrated that
L. pentosus LB3F2 had antimicrobial and antibiofilm
activity against S. aureus SA3 [29].
A comparison between bacterial growth curves in the
presence or absence of TCUESC01 supernatant at 50 %
of the MIC (10 mg∙mL−1) revealed this concentration
was not lethal to S. aureus CCMB262. This indicates
that the decrease in biofilm formation was not caused by
death of the pathogen (Fig. 3). Instead, TCUESC01
appeared to secrete a modulatory substance capable of
interfering with the pathogen’s capacity to form biofilms.
To confirm the results on biofilm inhibition, we visual-
ized its structural organization by confocal microscopy
Fig. 5 Thickness of S. aureus CCMB262 biofilm treated with L.
plantarum TCUESC02 supernatant at subinhibitory doses. Treatments
were as follows: C, untreated control; 70 %, 70 % of the MIC
(1.75 mg mL−1); 90 %, 90 % of the MIC (2.25 mg mL−1). No
significant difference could be observed
Fig. 6 Thickness of S. aureus CCMB262 biofilm treated with L.
fermentum TCUESC01 supernatant at subinhibitory doses. Treatments
were as follows: C, untreated control; 50 %, 50 % of the MIC
(10 mg mL−1); 70 %, 70 % of the MIC (14 mg mL−1); 90 %, 90 %
of the MIC (18 mg mL−1).*, statistical significance at p < 0.05,
analysis of variance
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(Fig. 4). To this end, we used two fluorescent nucleic
acid stains, DAPI and PI. DAPI penetrates the mem-
brane of viable cells, whereas PI cannot access intact
cells and only stains dead cells. The biofilm of S. aureus
CCMB262 presented an irregular distribution of living
and dead cells, with dense clusters of eDNA/dead cells.
Treatment with TCUESC01 supernatant (90, 70, and 50 %
of the MIC) substantially reduced S. aureus biomass, with
a proportional decrease in both living and dead cells. A
reduced amount of eDNA and/or dead cells was observed
also in the biofilm of S. aureus treated with TCUESC02
supernatant (Fig. 5). eDNA is one of the main components
of biofilms [4]. It functions as a cohesive factor between
bacteria, stabilizing the overall biofilm structure [30].
Moreover, it increases resistance to antimicrobials, such as
aminoglycosides [31] and vancomycin [32]. Thus, reduc-
tion of eDNA production represents a potential tool for
microbial control.
Microscopy analysis revealed also a significant reduction
in S. aureus biolfilm thickness at all tested subinhibitory
concentrations of L. fermentum TCUESC01 supernatant
(p < 0.05). Whereas the average thickness of the biofilm in
Fig. 7 Scanning electron microscopy of S. aureus CCMB262 biofilm treated or not with L. fermentum TCUESC01 supernatant. Treatments were as
follows: a untreated control; b 50 % of the MIC
Fig. 8 Real-time quantification of icaA and icaR expression in S. aureus CCMB262 treated or not with L. fermentum TCUESC01 supernatant. a
Relative quantification (RQ) of icaA. b RQ of icaR. Treatments were as follows: 1, untreated control; 2, 50 % of the MIC. Values correspond to RQs
(2-ΔΔCT) normalized to16S rRNA.*, statistical significance at p < 0.05, t-test
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the control was 14 μm, samples treated with 90 %
(18 mg∙mL−1), 70 % (14 mg∙mL−1), and 50 % (10 mg∙mL−1)
of the MIC presented a thickness of 2.83, 3.12, and
5.21 μm, respectively (Fig. 6). It should be noted, that
TCUESC02 did not cause any significant reduction in bio-
film thickness.
To visualize the intimate structure of the S. aureus
biofilm we used SEM. Following treatment with L. fermen-
tum TCUESC01 supernatant (50 % of the MIC), we
noticed a decrease in the biofilm matrix (Fig. 7), suggest-
ing possible interference with the production of PIAs.
PIA synthesis depends on the icaADBC locus [7]. Thus,
we sought to verify whether the phenotypic modulation of
S. aureus biofilm by L. fermentum TCUESC01 was related
to the genetic regulation of icaA and icaR genes. We
observed that treatment with L. fermentum supernatant
(50 % of the MIC) significantly increased the expression of
S. aureus regulator gene icaR. Accordingly, RQ increased
from 1 (untreated) to 68.45 (treated) (Fig. 8a), while icaA
expression dropped from a RQ of 1 (untreated) to 0.39
(treated) (Fig. 8b). These results suggest that the reduction
of S. aureus CCMB262 biofilm upon treatment with
TCUESC01 is associated with inhibition of PIA production.
Biofilms are formed by planktonic cells that bind irre-
versibly to a solid substrate. Wrapped in a matrix, cells
multiply, differentiate, and modify gene expression
patterns, in addition to creating channels for nutrient
circulation [33]. After ripening, fragments of this bacter-
ial community scatter, carrying all the “mother” commu-
nity features such as antimicrobial resistance and
virulence, and adhere elsewhere to repeat the cycle [34].
When organized into biofilms, bacteria tend to become
more pathogenic. Suci et al. (1994) demonstrated the
delayed penetration of ciprofloxacin into biofilms of
Pseudomonas aeruginosa ERC-1 [35]. Seemingly, Ceri et
al. (1999) found that the MIC of some antibiotics was
around 100 to 1000 times greater for microorganisms in
biofilms [36]. These findings underscore the importance
of developing new strategies to combat biofilms, such as
the use of probiotics. Here, L. fermentum TCUESC01 and
L. plantarum TCUESC02 showed bactericidal properties
against S. aureus CCMB262. Furthermore, TCUESC01
was able to reduce the formation of S. aureus biofilms
under subinhibitory conditions. In addition, increased
icaR and reduced icaA expression in S. aureus cultures
treated with TCUESC01 supernatant indicated that the
reduction in biofilm production occurred through modu-
lation of the ica operon.
Conclusions
The results presented in this study suggest an interesting
novel application for lactobacilli isolated from fine
cocoa. The antimicrobial effect and biofilm inhibition
exhibited by the probiotic strain TCUESC01 could be
applied to the treatment and prevention of infections
with pathogenic bacterial strains.
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